Chlorophyll accumulation and chloroplast development are regulated at multiple levels during plant development. The paralogous LLM-domain B-GATA transcription factors GNC and GNL contribute to chlorophyll biosynthesis and chloroplast formation in light-grown seedlings. Whereas there is already ample knowledge about the transcriptional regulation of and , the identity of their downstream targets is largely unclear. Here, we identified genes controlling greening directly downstream of the GATAs by integrating data from RNA-sequencing and microarray data sets. We found that genes encoding subunits of the Mg-chelatase complex and 3,8-divinyl protochlorophyllide a 8-vinyl reductase (DVR) likely function directly downstream of the GATAs and that expression is limiting in the pale-green mutants. The GATAs also regulate the nucleus-encoded () factor genes, which control transcription in the chloroplast and suppress the greening defects of mutants. Furthermore, and act, at the gene expression level, in an additive manner with the () and transcription factor genes, which are also important for proper chlorophyll accumulation. We thus reveal that chlorophyll biosynthesis genes are directly controlled by LLM-domain B-GATAs and demonstrate that these transcription factors play an indirect role in the control of greening through regulating factor genes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894840 | PMC |
http://dx.doi.org/10.1105/tpc.17.00947 | DOI Listing |
Sci Prog
January 2025
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Despite advances in multimodal cancer therapy, such as combining radical surgery with high-intensity chemoradiotherapy, for SMARCB1/INI-1-deficient sinonasal carcinoma (SDSC), the prognosis of patients remains poor. Immunotherapy is gaining increasing popularity as a novel treatment strategy for patients with SMARCB1/INI-1-deficient tumors. Herein, we report on the management of three patients with SDSC who received PD-1/PD-L1 inhibitor therapy as a part of multimodal therapy based on surgery and chemoradiotherapy.
View Article and Find Full Text PDFVaccine X
October 2024
Clinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Israel, affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
Purpose: This study aimed to evaluate the attitudes of Israeli elderly population towards COVID-19 and influenza vaccines, and to assess factors contributing to these attitudes.
Methods: Four-hundred and one participants exhibiting symptoms consistent with COVID-19 or influenza were enrolled and filled out a questionnaire. A second questionnaire was filled out for hospitalized patients at discharge.
RSC Chem Biol
January 2025
Department of Molecular Biosciences, University of Texas Austin Texas USA
RNA polymerase II (Pol II) regulates eukaryotic gene expression through dynamic phosphorylation of its C-terminal domain (CTD). Phosphorylation at Ser2 and Thr4 on the CTD is crucial for RNA 3' end processing and facilitating the recruitment of cleavage and termination factors. However, the transcriptional roles of most CTD-binding proteins remain poorly understood.
View Article and Find Full Text PDFMol Ther Oncol
March 2025
Molecular Oncology Laboratory, Department of Zoology, University of Delhi (North Campus), New Delhi, India.
Human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) encompasses a heterogeneous group of malignancies characterized by diverse clinical manifestations. Notably, HPV-positive HNSCC exhibits a more favorable prognosis, particularly when the virus is transcriptionally active. This study aimed to elucidate the role of key transcription factors in activating the HPV long control region (LCR), responsible for its oncogenic potential.
View Article and Find Full Text PDFMediterr J Rheumatol
December 2024
Department of Immunology & Molecular Medicine.
Introduction: The interferon regulatory factor 7 (IRF7), a member of the IRF family of transcription factors, plays a major role in the regulation of numerous aspects of an immune response and has increasingly been surveyed to determine the aetiology and pathogenesis of systemic sclerosis (SSc). Objective: This study aimed to investigate the transcriptional levels of IRF7 mRNA in peripheral blood mononuclear cells (PBMCs) and the impact of promoter methylation on IRF7 mRNA expression in SSc patients compared to healthy controls.
Methods: PBMCs were obtained from confirmed 40 naïve SSc cases and 20 healthy controls for IRF-7 expression and methylation analysis.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!